நரம்பியல் கண்டுபிடிப்பு மன்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நரம்பியல் கண்டுபிடிப்பு மன்றம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நரம்பியல் கண்டுபிடிப்பு மன்றம் Today - Breaking & Trending Today

GB Sciences Featured & Speaking at the SACHS Associates' 4th Annual Neuroscience Innovation Forum


GB Sciences Featured & Speaking at the SACHS Associates 4th Annual Neuroscience Innovation Forum
LAS VEGAS, NV / ACCESSWIRE / April 27, 2021 / GB Sciences (GBS), Inc. (OTCQB:GBLX), a leading phytomedicine research and biopharmaceutical development company, will be featured during the SPOTLIGHT SHOWCASE at the SACHS Associates 4th Annual Neuroscience Innovation Forum (NIF) for Business Development, Licensing & Investment from April 28 to April 30. The SACHS NIF, which is entirely virtual, will include a SPOTLIGHT SHOWCASE session describing GB Sciences recent pivot and novel drug development pipeline. In addition, Dr. Andrea Small-Howard, the Chief Science Officer and Director of GB Sciences, is an invited speaker on the Pain, Migraines, and Addiction Panel during a live session on Therapeutics Day 2, April 29 at 11:50 a.m. EDT. ....

Mark Demitrack , Norbert Riedel , Seth Lederman , Randall Stevens , Las Vegas , Pradeep Banerjee , Neuroscience Innovation Forum For Business Development , Neuroscience Innovation Forum , Trevena Inc , Contract Research Organizations , Gb Sciences Gbs Inc , Exchange Commission , Addiction Panel , Centrexion Therapeutics Corp , Gb Sciences , Gb Sciences Inc , Tonix Pharmaceuticals Holding Corp , Aptinyx Inc , Abbvie Inc , Global Biopharma Inc , Business Development , Annual Neuroscience Innovation Forum , Andrea Small Howard , Chief Science Officer , Therapeutics Day , Executive Director ,

Addex to Participate at the 4ᵗʰ Annual Neuroscience Innovation Forum


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Addex to Participate at the 4ᵗʰ Annual Neuroscience Innovation Forum
Addex TherapeuticsApril 26, 2021 GMT
Geneva, Switzerland, April 26, 2021 - Addex Therapeutics  Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Tim Dyer, Chief Executive Officer, will present at the 4ᵗʰ Annual Neuroscience Innovation Forum (April 26 - 30, 2021).
In his presentation, Mr Dyer will provide a corporate update and discuss recent developments at Addex. The video presentation will be available for viewing to registered participants at the forum. Mr Dyer will also be speaking at the Parkinson’s & Movement Disorders Panel scheduled for 13:20 EDT, April 28, 2021. ....

Tim Dyer , Mike Sinclair , Company Annual Report On Form , Parkinson Movement Disorders Panel , Neuroscience Innovation Forum , Addex Therapeutics Ltd , Janssen Pharmaceuticals Inc , Swiss Exchange , Therapeutics Ltd , Chief Executive Officer , Annual Neuroscience Innovation Forum , Movement Disorders Panel , Addex Therapeutics , Janssen Pharmaceuticals , Halsin Partners , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Globe Newswire , நேரம் சாய தொழிலாளி , மைக் சின்க்ளேர் , நிறுவனம் ஆண்டு அறிக்கை ஆன் வடிவம் , நரம்பியல் கண்டுபிடிப்பு மன்றம் , ஜான்சன் மருந்துகள் இன்க் , சுவிஸ் பரிமாற்றம் , சிகிச்சை லிமிடெட் ,